Singapore markets closed

iTeos Therapeutics, Inc. (ITOS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.95-0.30 (-1.97%)
At close: 04:00PM EDT
14.95 0.00 (0.00%)
After hours: 04:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 540.04M
Enterprise value 96.72M
Trailing P/E 2.46
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.42
Price/book (mrq)1.00
Enterprise value/revenue -0.31
Enterprise value/EBITDA -0.44

Trading information

Stock price history

Beta (5Y monthly) 1.43
52-week change 310.01%
S&P500 52-week change 325.22%
52-week high 318.75
52-week low 38.20
50-day moving average 314.44
200-day moving average 311.65

Share statistics

Avg vol (3-month) 3424.11k
Avg vol (10-day) 3337.21k
Shares outstanding 536.12M
Implied shares outstanding 636.12M
Float 824.99M
% held by insiders 10.70%
% held by institutions 198.80%
Shares short (15 May 2024) 42.16M
Short ratio (15 May 2024) 43.81
Short % of float (15 May 2024) 411.29%
Short % of shares outstanding (15 May 2024) 45.97%
Shares short (prior month 15 Apr 2024) 42.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-15.59%
Return on equity (ttm)-22.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -168.44M
Net income avi to common (ttm)-135.31M
Diluted EPS (ttm)-3.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)449.14M
Total cash per share (mrq)12.43
Total debt (mrq)5.82M
Total debt/equity (mrq)1.08%
Current ratio (mrq)13.51
Book value per share (mrq)15.10

Cash flow statement

Operating cash flow (ttm)-109.6M
Levered free cash flow (ttm)-89.4M